Moderna, Inc. vs Teladoc Health Inc — how do they compare? Moderna, Inc. trades at $59.72 (market cap $23.60B), while Teladoc Health Inc trades at $9.7 (market cap $1.74B). The key difference: Moderna, Inc. is far larger — about 13.6× Teladoc Health Inc's market cap, and Teladoc Health Inc is trading nearer its 52-week high, Moderna, Inc. nearer its low. Which is the better fit depends on your goals.
| MRNA | TDOC | |
|---|---|---|
Market Cap | $23.60B | $1.74B |
Sector | Health | Health |
52-Week High | $81.80 | $9.72 |
52-Week Low | $22.36 | $4.47 |
Enterprise Value | $19.70B | $2.03B |
Trailing returns across standard periods
Latest headlines on both assets
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →Teladoc Health is a virtual health provider with a telehealth platform delivering 24-hour, on-demand healthcare via mobile devices, the internet, video, and phone. It also offers remote patient monitoring programs for chronic care management. Its platform connects members with a network of physicians and behavioral health professionals. Most of the company's revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems. Since inception, Teladoc has primarily partnered with employers, health plans, and health systems to offer network access to their members.
Read more on TDOC →